Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
268.3 USD | -4.16% | -2.12% | -16.92% |
05-08 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
05-08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.92% | 7.71B | |
-4.66% | 183B | |
-1.01% | 108B | |
-4.20% | 67.51B | |
+2.68% | 50.67B | |
+9.12% | 44.7B | |
+3.21% | 40.95B | |
+4.13% | 26.71B | |
+3.31% | 26.8B | |
+13.35% | 24.62B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Transcript : Bio-Rad Laboratories, Inc. Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 02